Measuring spasticity and fine motor control (Pinch) change in the hand after botulinum toxin-a injection using dynamic computerized hand dynamometry

Archives of Physical Medicine and Rehabilitation

Volumn 95, Issue 12, 2014, Pages 2402-2409

  Barden, Hannah L Holman ^a,b   Baguley, Ian James ^a,c   Nott, Melissa Therese ^a,d   Chapparo, Christine ^b  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Adult; Muscle spasticity; Muscle strength dynamometer; Pinch strength; Rehabilitation; Upper extremity

Indexed keywords

BOTULINUM TOXIN A; MUSCLE RELAXANT AGENT;

ACQUIRED BRAIN INJURY; ACTION RESEARCH ARM TEST; ADULT; ARM; ARM MUSCLE; ARTICLE; ASSESSMENT OF HUMANS; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DYNAMIC COMPUTERIZED DYNAMOMETRY; DYNAMOMETRY; FEMALE; GOAL ATTAINMENT SCALE; HUMAN; MALE; MICHIGAN HAND OUTCOMES QUESTIONNAIRE; MIDDLE AGED; MODIFIED ASHWORTH SCALE; MOTOR CONTROL; MOTOR PERFORMANCE; MUSCLE STRENGTH; OPEN STUDY; PINCH STRENGTH; PRETEST POSTTEST DESIGN; SELF CONCEPT; SPASTICITY; STRETCHING EXERCISE; TARDIEU SCALE; TRAUMATIC BRAIN INJURY; BRAIN INJURY; COMPLICATION; DYNAMOMETER; HAND; MOTOR NEURON DISEASE; MUSCLE SPASTICITY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BOTULINUM TOXINS, TYPE A; BRAIN INJURIES; FEMALE; HAND; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; MOTOR SKILLS; MUSCLE SPASTICITY; MUSCLE STRENGTH DYNAMOMETER; NEUROMUSCULAR AGENTS; PINCH STRENGTH;

EID: 84922480424     PISSN: 00039993     EISSN: 1532821X     Source Type: Journal    
DOI: 10.1016/j.apmr.2014.05.017     Document Type: Article

References (40)

1. Johanson ME, Valero-Cuevas FJ, Hentz VR. Activation patterns of the thumb muscles during stable and unstable pinch tasks. J Hand Surg Am 2001; 26A: 698-705.
2. Barnes MP. An overview of the clinical management of spasticity. In: Barnes MP, Johnson GR, editors. Upper motor neurone syndrome and spasticity: Clinical management and neurophysiology. 2nd ed. Cambridge: Cambridge Univ Pr; 2008. p 1-8.
3. Bakheit AM, Pittock S, Moore AP, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 2001; 8: 559-65.
4. Chang C, Munin MC, Skidmore ER, Niyonkuru C, Huber LM, Weber DJ. Effect of baseline spastic hemiparesis on recovery of upperlimb function following botulinum toxin type A injections and postinjection therapy. Arch Phys Med Rehabil 2009; 90: 1462-8.
5. McCrory P, Turner-Stokes L, Baguley IJ, et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med 2009; 41: 536-44.
6. Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: International consensus statement. Eur J Neurol 2010; 17: 74-93.
7. Wissel J,Ward AB, Erztgaard P, et al. European consensus table on the use of botulinumtoxin typeAin adult spasticity. J RehabilMed 2009; 41: 13-25.
8. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial. Neurology 1996; 46: 1306-10.
9. Bakheit AM, Thilmann AF, Ward AB, et al. A randomized, doubleblind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 2000; 31: 2402-6.
10. Rosales RL, Chua-Yap AS. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm 2008; 115: 617-23.
11. Simpson DM, Gracies JM, Graham HK, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology 2008; 70: 1691-8.
12. Burridge JH, Wood DE, Hermens HJ, et al. Theoretical and methodological considerations in the measurement of spasticity. Disabil Rehabil 2005; 27: 69-80.
13. Royal College of Physicians, Brisitsh Society of Rehabilitation Medicine, Chartered Society of Physiotherapy, Association of Chartered Physiotherapists Interested in Neurology. Spasticity in adults: Management using botulinum toxin. National guidelines. London: Royal College of Physicians; 2009.
14. Caty GD, Detrembleur C, Bleyenheuft C, Deltombe T, Lejeune T. Effect of upper limb botulinum toxin injections on impairment, activity, participation, and quality of life among stroke patients. Stroke 2009; 40: 2589-91.
15. Brashear A, Gordon MF, Elovic E, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 2002; 347: 395-400.
16. Francis HP, Wade DT, Turner-Stokes L, Kingswell RS, Dott CS, Coxon EA. Does reducing spasticity translate into functional benefit? An exploratory meta-Analysis. J Neurol Neurosurg Psychiatry 2004; 75: 1547-51.
17. Foley N, Pereira S, Salter K, et al. Treatment with botulinum toxin improves upper-extremity function post stroke: A systematic review and meta-Analysis. Arch Phys Med Rehabil 2013; 94: 977-89.
18. Ada L, O'Dwyer N, O'Neill E. Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: An observational study. Disabil Rehabil 2006; 28: 891-7.
19. Ranka J, Chapparo C. Motor aspects of upper limb functioning and occupation analysis. In: Mackenzie L, O'Toole G, editors. Occupation analysis in practice. West Sussex: Wiley-Blackwell; 2011. p 264-79.
20. Barden HL, Nott MT, Heard R, Chapparo C, Baguley IJ. Clinical assessment of hand motor performance after acquired brain injury with dynamic computerized hand dynamometry: Construct, concurrent, and predictive validity. Arch Phys Med Rehabil 2012; 93: 2257-63.
21. Sivan M, O'Connor RJ, Makower S, Levesley M, Bhakta B. Systematic review of outcome measures used in the evaluation of robotassisted upper limb exercise in stroke. J Rehabil Med 2011; 43: 181-9.
22. Turner-Stokes L, Fheodoroff K, Jacinto J, Maisonobe P, Zakine B. Upper limb international spasticity study: Rationale and protocol for a large, international, multicentre prospective cohort study investigating management and goal attainment following treatment with botulinum toxin A in real-life clinical practice. BMJ Open 2013; 3: 1-12.
23. Baguley IJ, Nott MT, Barden HLH. The use of computerised dynamometry to quantify functional grip and release in people post stroke: A pilot study. Open Rehabil J 2010; 3: 75-82.
24. Barden HL, Baguley IJ, Nott MT, Heard R, Chapparo C. The reliability and validity of computerised pinch dynamometry in the assessment of adult hand spasticity. Aust Occup Ther J; in press.
25. Barden HL, Nott MT, Baguley IJ, Heard R, Chapparo C. Testeretest reliability of computerised hand dynamometry in adults with acquired brain injury. Aust Occup Ther J 2012; 59: 319-27.
26. Barden HL, Baguley IJ, Nott MT, Chapparo C. Dynamic computerised hand dynamometry: Measuring outcomes following upper limb botulinum toxin-A injections in adults with acquired brain injury. J Rehabil Med 2014; 46: 314-20.
27. Puh U. Age-related and sex-related differences in hand and pinch grip stength in adults. Int J Rehabil Res 2010; 33: 4-11.
28. Roberts HC, Denison HJ, Martin HJ, et al. A review of the measurement of grip strength in clinical and epidemiological studies: Towards a standardised approach. Age Ageing 2011; 40: 423-9.
29. Bohannon RW, Smith MB. Interrater reliability of a Modified Ashworth Scale of muscle spasticity. Phys Ther 1987; 67: 206-7.
30. Tardieu G, Shentoub S, Delarue R. A la recherche d'une technique de mesure de la spasticité[French]. Rev Neurol (Paris) 1954; 91: 143-4.
31. Yelnik AP, Simon O, Parratte B,Gracies JM. How to clinically assess and treatmuscle overactivity in spastic paresis. JRehabilMed 2010; 42: 801-7.
32. Platz T, Pinkowski C, Van Wijck F, Johnson G. ARM-Arm Rehabilitation Measurement: Manual for performance and scoring of the Fugl-Meyer test (arm section), Action Research Arm test, and the Box-And-Block test. Baden, Germany: Deutscher Wissenschafts-Verlag; 2005.
33. McDonnell MN, Hillier SL, Ridding MC, Miles TS. Impairments in precision grip correlate with functional measures in adult hemiplegia. Clin Neurophysiol 2006; 117: 1474-80.
34. Li KY, Lin KC, Wang TN, Wu CY, Huang YH, Ouyang P. Ability of three motor measures to predict functional outcomes reported by stroke patients after rehabilitation. Neurorehabilitation 2012; 30: 267-75.
35. Chung KC, Hamill JB, Walters MR, Hayward RA. The Michigan Hand Outcomes Questionnaire (MHQ): Assessment of responsiveness to clinical change. Ann Plast Surg 1999; 42: 619-22.
36. Turner-Stokes L. Goal attainment scaling (GAS) in rehabilitation: A practical guide. Clin Rehabil 2009; 23: 362-70.
37. Corder GW, Foreman DI. Nonparametric statistics for nonstatisticians: A step-by-step approach. Hoboken: John Wiley and Sons, Inc; 2009.
38. Portney LG, Watkins MP. Foundations of clinical research: Applications to practice. 3rd ed. New Jersey: Pearson Education; 2009.
39. van der Lee JH, de Groot V, Beckerman H, Wagenaar RC, Lankhorst GJ, Bouter LM. The intra-And interrater reliability of the action research arm test: A practical test of upper extremity function in patients with stroke. Arch Phys Med Rehabil 2001; 82: 14-9.
40. Baguley IJ, Nott MT, Turner-Stokes L, et al. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity. J Rehabil Med 2011; 43: 1032-7.